The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine ...

The HSS has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting bird flu.

The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying ...

Moderna announced that HHS is withdrawing millions of dollars it had pledged to support the company’s efforts to develop a human avian flu vaccine. During the Biden administration, HHS announced plans ...

THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.

The FDA also approved treprostinil (Yutrepia) inhalation powder for patients with pulmonary arterial hypertension and ...

In 2015, doctors who attended the top 20 ranked medical schools had 52% lower odds of going on to practice in ...

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.

Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals ...

Spero and GSK halt a UTI drug trial due to early success; Sanofi plans vaccine production in Vietnam; Brazil investigates ...